Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis (English)
- New search for: Thyssen, J.P.
- New search for: Yosipovitch, G.
- New search for: Paul, C.
- New search for: Kwatra, S.G.
- New search for: Chu, C.‐Y.
- New search for: DiBonaventura, M.
- New search for: Feeney, C.
- New search for: Zhang, F.
- New search for: Myers, D.
- New search for: Rojo, R.
- New search for: Valdez, H.
- New search for: Thyssen, J.P.
- New search for: Yosipovitch, G.
- New search for: Paul, C.
- New search for: Kwatra, S.G.
- New search for: Chu, C.‐Y.
- New search for: DiBonaventura, M.
- New search for: Feeney, C.
- New search for: Zhang, F.
- New search for: Myers, D.
- New search for: Rojo, R.
- New search for: Valdez, H.
In:
Journal of the European Academy of Dermatology and Venereology
;
36
, 3
;
434-443
;
2022
- Article (Journal) / Electronic Resource
-
Title:Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis
-
Contributors:Thyssen, J.P. ( author ) / Yosipovitch, G. ( author ) / Paul, C. ( author ) / Kwatra, S.G. ( author ) / Chu, C.‐Y. ( author ) / DiBonaventura, M. ( author ) / Feeney, C. ( author ) / Zhang, F. ( author ) / Myers, D. ( author ) / Rojo, R. ( author )
-
Published in:Journal of the European Academy of Dermatology and Venereology ; 36, 3 ; 434-443
-
Publisher:
-
Publication date:2022-03-01
-
Size:443 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 36, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 317
-
Issue Information| 2022
- 323
-
Editor's Picks| 2022
- 324
-
Deciphering the influence of smoking in adults with atopic dermatitisAoki, Valeria / Orfali, Raquel Leão et al. | 2022
- 326
-
Patient‐reported outcomes in adult atopic dermatitis are useful in both clinical trials and real‐life clinical practiceStingeni, L. / Marietti, R. / Tramontana, M. / Bianchi, L. / Hansel, K. et al. | 2022
- 328
-
Pioneers in Dermatology and Venereology: an interview with Professor Ana KaminskyKaminsky, A. et al. | 2022
- 332
-
European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statementApalla, Z. / Nikolaou, V. / Fattore, D. / Fabbrocini, G. / Freites‐Martinez, A. / Sollena, P. / Lacouture, M. / Kraehenbuehl, L. / Stratigos, A. / Peris, K. et al. | 2022
- 351
-
Position paper on a simplified histopathological classification of basal cell carcinoma: results of the European Consensus ProjectFernández‐Figueras, M.T. / Malvehi, J. / Tschandl, P. / Rutten, A. / Rongioletti, F. / Requena, L. / Kittler, H. / Kerl, K. / Kazakov, D. / Cribier, B. et al. | 2022
- 360
-
New regulation of medical devices in the EU: impact in dermatologyMalvehy, J. / Ginsberg, R. / Sampietro‐Colom, L. / Ficapal, J. / Combalia, M. / Svedenhag, P. et al. | 2022
- 365
-
Novel functions of S1P in chronic itchy and inflammatory skin diseasesGray, N. / Limberg, M.M. / Bräuer, A.U. / Raap, U. et al. | 2022
- 373
-
Association of vitiligo with high‐frequency sensorineural hearing loss: a systematic review and meta‐analysisLien, K.‐H. / Ger, T.‐Y. / Chi, C.‐C. et al. | 2022
- 380
-
Pharmacological interventions for periorificial (perioral) dermatitis in children and adults: a systematic reviewGray, N.A. / Tod, B. / Rohwer, A. / Fincham, L. / Visser, W.I. / McCaul, M. et al. | 2022
- 391
-
Digital dermoscopy monitoring of melanocytic lesions: Two novel calculators combining static and dynamic features to identify melanomaZenone, M. / Zocchi, L. / Moccia, C. / Passerini, S.G. / Sanavia, T. / Fariselli, P. / Broganelli, P. / Ribero, S. / Maule, M. / Quaglino, P. et al. | 2022
- 403
-
Freedom from disease in psoriasis: a Delphi consensus definition by patients, nurses and physiciansvan Ee, I. / Deprez, E. / Egeberg, A. / Augustin, M. / Conrad, C. / Corazza, V. / Donati, L. / Lambert, J. / Lăpădatu, R. / Meyer, A. et al. | 2022
- 413
-
Atopic dermatitis: disease characteristics and comorbidities in smoking and non‐smoking patients from the TREATgermany registryPilz, A.C. / Schielein, M.C. / Schuster, B. / Heinrich, L. / Haufe, E. / Abraham, S. / Heratizadeh, A. / Harder, I. / Kleinheinz, A. / Wollenberg, A. et al. | 2022
- 422
-
Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate‐to‐severe atopic dermatitis: an analysis of patient‐reported outcomesCork, M.J. / McMichael, A. / Teng, J. / Valdez, H. / Rojo, R. / Chan, G. / Zhang, F. / Myers, D.E. / DiBonaventura, M. et al. | 2022
- 434
-
Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitisThyssen, J.P. / Yosipovitch, G. / Paul, C. / Kwatra, S.G. / Chu, C.‐Y. / DiBonaventura, M. / Feeney, C. / Zhang, F. / Myers, D. / Rojo, R. et al. | 2022
- 444
-
An objective skin‐type classification based on non‐invasive biophysical parametersSeo, J.I. / Ham, H.I. / Baek, J.H. / Shin, M.K. et al. | 2022
- 453
-
Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open‐label extension phaseWeisshaar, E. / Szepietowski, J.C. / Bernhard, J.D. / Hait, H. / Legat, F.J. / Nattkemper, L. / Reich, A. / Sadoghi, B. / Sciascia, T.R. / Zeidler, C. et al. | 2022
- 462
-
Primary alterations during the development of hidradenitis suppurativaDajnoki, Z. / Somogyi, O. / Medgyesi, B. / Jenei, A. / Szabó, L. / Gáspár, K. / Hendrik, Z. / Gergely, P. / Imre, D. / Póliska, S. et al. | 2022
- 472
-
Ichthyosis, psoriasiform dermatitis, and recurrent fungal infections in patients with biallelic mutations in PERPYoussefian, L. / Khodavaisy, S. / Khosravi‐Bachehmir, F. / Park, J.S. / Saeidian, A.H. / Mahmoudi, H. / Saffarian, Z. / Naraghi, Z.S. / Kamyab‐Hesari, K. / Zeinali, S. et al. | 2022
- 480
-
Announcement| 2022
- e158
-
Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workersRerknimitr, P. / Puaratanaarunkon, T. / Wongtada, C. / Wittayabusarakam, N. / Krithin, S. / Paitoonpong, L. / Kumtornrut, C. / Kerr, S.J. / Asawanonda, P. / Jantarabenjakul, W. et al. | 2022
- e161
-
Erythema nodosum following the first dose of ChAdOx1‐S nCoV‐19 vaccineCameli, N. / Silvestri, M. / Mariano, M. / Bennardo, L. / Nisticò, S.P. / Cristaudo, A. et al. | 2022
- e162
-
Regression of common viral warts after ChAdOx1‐S COVID‐19 vaccinePłaszczyńska, A. / Sławińska, M. / Sobjanek, M. et al. | 2022
- e164
-
Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severityMolinier, R. / Roger, A. / Genet, B. / Blom, A. / Longvert, C. / Chaplain, L. / Fort, M. / Saiag, P. / Funck‐Brentano, E. et al. | 2022
- e166
-
Is there a POST‐COVID dermatological syndrome? The integrated dermato‐infectious disease experience of a single centreDiotallevi, F. / Mazzanti, S. / Properzi, P. / Olivieri, S. / Giacometti, A. / Offidani, A. et al. | 2022
- e169
-
Non‐invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS‐COV‐2 infection in adult and childrenProietti, I. / Tolino, E. / Mambrin, A. / Skroza, N. / Bernardini, N. / Marchesiello, A. / Marraffa, F. / Michelini, S. / Rossi, G. / Volpe, S. et al. | 2022
- e171
-
Eosinophilic dermatosis after AstraZeneca COVID‐19 vaccinationCinotti, E. / Perrot, J.‐L. / Bruzziches, F. / Tognetti, L. / Batsikosta, A. / Sorrentino, E. / Marzano, A.V. / Rubegni, P. et al. | 2022
- e172
-
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID‐19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta‐like eruptionSernicola, A. / Dybala, A. / Gomes, V. / Maddalena, P. / Adotti, F. / Soda, G. / Muharremi, R. / Fino, P. / Del Duca, E. / Grieco, T. et al. | 2022
- e174
-
At‐risk circumstances for COVID‐19 increase the risk of pruritus: cross‐sectional and longitudinal analysesKogame, T. / Ogawa, Y. / Kabashima, K. / Yamamoto, Y. et al. | 2022
- e175
-
Dermatological emergency unit, day‐care hospital and consultations in time of COVID‐19: the impact of teledermatologyBrehon, A. / Shourick, J. / Hua, C. / Skayem, C. / Wolkenstein, P. / Chosidow, O. / Duong, T.A. et al. | 2022
- e177
-
Lack of association between seborrheic dermatitis and SARS‐CoV‐2 outcomesRakita, U. / Kaundinya, T. / Guraya, A. / Nelson, K. / Maner, B. / Manjunath, J. / Schwartzman, G. / Lane, B. / Silverberg, J.I. et al. | 2022
- e179
-
Subacute cutaneous lupus erythematosus induction after SARS‐CoV‐2 vaccine in a patient with primary biliary cholangitisZengarini, C. / Pileri, A. / Salamone, F.P. / Piraccini, B.M. / Vitale, G. / La Placa, M. et al. | 2022
- e180
-
COVID‐19 cutaneous manifestations in pediatric patients: 24 multisystem inflammatory syndrome in children and six Kawasaki disease casesTammaro, A. / Karim, D. / Adebanjo, G.A.R. / Parisella, F.R. / Chello, C. / Salih, A.F. / Rello, J. et al. | 2022
- e182
-
Multisystem inflammatory syndrome in adults (MIS‐A): a new addition to COVID‐19 puzzleHajra, K. / Chakraborty, U. / Chatterjee, K. / Chandra, A. / Halder, S. et al. | 2022
- e185
-
Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccinationKuzumi, A. / Yoshizaki, A. / Chiba, K. / Mitsuo, S. / Matsuda, K.M. / Norimatsu, Y. / Nagai, K. / Omatsu, J. / Miyake, T. / Sato, S. et al. | 2022
- e186
-
Pityrosporum folliculitis in critically ill COVID‐19 patientsPeres, F.L.X. / Bonamigo, R.R. / Bottega, G.B. / Staub, F.L. / Cartell, A.S. / Bakos, R.M. et al. | 2022
- e188
-
Concomitant SARS‐CoV‐2 infection and crusted scabies in a 4‐month infantGiannattasio, A. / Rosa, M. / Esposito, S. / Di Mita, O. / Angrisani, F. / Acierno, S. / D’Anna, C. / Barbato, F. / Tipo, V. / Ametrano, O. et al. | 2022
- e190
-
Trend of sexually transmitted infections during the Covid‐19 age. What was the impact of the pandemic and the social distancing measures?Ronga, L. / Stolfa, S. / Romanelli, F. / Bavaro, D.F. / Saracino, A. / Mosca, A. / Sparapano, E. / De Carlo, C. / Montagna, M.T. / Diella, G. et al. | 2022
- e192
-
EczemaPartner – adapting a questionnaire to assess the impact of atopic dermatitis on partners of patientsShourick, J. / Taieb, C. / Seneschal, J. / Merhand, S. / Ezzedine, K. / Halioua, B. / Richard, M.A. / Mrowietz, U. et al. | 2022
- e193
-
Should we consider broad‐spectrum quinolone antibacterial agent as acne treatment in the antimicrobial resistance era?Ruffier d'Epenoux, L. / Guillouzouic, A. / Bémer, P. / Dagnelie, M.‐A. / Khammari, A. / Dréno, B. / Corvec, S. et al. | 2022
- e195
-
Analysis of cytokines in tear fluid from atopic dermatitis patients with dupilumab‐associated ocular adverse eventsVuillemey, L. / Febvay, C. / Puzenat, E. / Bellanger, A.P. / Chague, C. / Puyraveau, M. / Delbosc, B. / Gauthier, A.‐S. / Aubin, F. et al. | 2022
- e197
-
Association of atopic dermatitis severity with menstrual worsening of disease in women: a cross‐sectional studyRakita, U. / Kaundinya, T. / Silverberg, J.I. et al. | 2022
- e200
-
Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patientsYin, L. / Svigos, K. / Gutierrez, D. / Peterson, E. / Lo Sicco, K. / Shapiro, J. et al. | 2022
- e202
-
Risk of de novo psoriasis in hypertension patients initially treated with beta‐blockers: Nationwide population‐based cohort study in KoreaKim, Y. E. / Cho, Y. / Jo, S. J. et al. | 2022
- e205
-
Women with moderate‐to‐severe psoriasis in Spain (BIOBADADERM registry) breastfeed less when compared with general populationRivera‐Diaz, R. / Llamas‐Velasco, M. / Carretero, G. / Ruíz‐Genao, D. / Belinchón, I. / Riera‐Monroig, J. / de la Cueva, P. / Ferrán, M. / de Vega, M. / García‐Doval, I. et al. | 2022
- e207
-
PPARα activation by fenofibrate ameliorates radiation‐induced skin injuryLiu, P. / Yu, D. / Sheng, W. / Geng, F. / Zhang, J. / Zhang, S. et al. | 2022
- e210
-
Phylloid hypermelanosis: further report of an unusual syndromeMortasawi, V. / König, A. / Pfützner, W. / Wolf, R. / Happle, R. et al. | 2022
- e212
-
Frontal fibrosing alopecia: a retrospective clinical review of 58 Egyptian patients with treatment outcome and long‐term follow‐upDorgham, N.A. / Hegazy, R. / Farag, A. / Dorgham, D.A. et al. | 2022
- e213
-
Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmedSibaud, V. / Brun, A. / Meyer, N. / Oberic, L. / Lamant, L. / Ysebaert, L. et al. | 2022
- e215
-
Mutations in SAM syndrome and palmoplantar keratoderma patients suggest genotype/phenotype correlations in DSG1 mutationsTakeuchi, S. / Takeichi, T. / Koike, Y. / Takama, H. / Tanahashi, K. / Okuno, Y. / Ishii, N. / Muro, Y. / Ogi, T. / Suga, Y. et al. | 2022
- e218
-
Toxic epidermal necrolysis‐like lupus erythematosus: a condition to exclude in all patients with possible Stevens‐Johnson syndrome/toxic epidermal necrolysisTruong, K. / Goldinger, S. / Kim, J. / Smith, A. / Fernandez‐Peñas, P. et al. | 2022
- e221
-
Evaluating for audiological differences in children with alopecia areataMcKenzie, P. L. / Rangu, S. / Wartinger, F. / Castelo‐Soccio, L. et al. | 2022
- e224
-
Minoxidil‐induced hypertrichosis in a breastfed infantTrüeb, R.M. / Caballero‐Uribe, N. et al. | 2022
- e225
-
Clinical characteristics of chronic nodular prurigo are independent of Fitzpatrick skin type: a European prospective cross‐sectional studyPereira, M. P. / Zeidler, C. / Ständer, S. et al. | 2022
- e227
-
Rosacea and upper gastrointestinal disorders: a case‐control study from a large, urban academic centreYi, J.Z. / Lukac, D. / Pagani, K. / Li, S. / McGee, J.S. et al. | 2022
- e229
-
Don't Judge a Book by its Cover. ‘Steroid Acne’: an unrecognized role of Malassezia and Demodex?Melin, A. / Chosidow, O. / Foulet, F. / Ingen‐Housz‐Oro, S. / Limal, N. / Audard, V. / Le Bras, F. / Botterel, F. / Fardet, L. / Bernigaud, C. et al. | 2022
- e232
-
Comment on ‘Don't Judge a Book by its Cover. “Steroid Acne”: an Unrecognized Role of Malassezia and Demodex?' by Melin et al.Tatu, A.L. / Nadasdy, T. et al. | 2022
- e233
-
Comparison of Secukinumab and Ixekizumab in psoriasis: a real‐life cohort study on the efficacy and drug survival of 445 patientsCariti, C. / Dapavo, P. / Mastorino, L. / Ortoncelli, M. / Siliquini, N. / Merli, M. / Avallone, G. / Giordano, S. / Fabrizio, R. / Susca, S. et al. | 2022
- e235
-
Papillon‐Lefevre syndrome treated by acitretin: case report and cytokine profileLeuenberger, M. / Fischer, L. / Mylonas, A. / Huber, M. / Di Domizio, J. / Gilliet, M. / Conrad, C. / Hohl, D. et al. | 2022
- e238
-
The burden of psoriasis on patient's caregiversBardazzi, F. / Clarizio, G. / Marani, A. / Tengattini, V. / Sacchelli, L. et al. | 2022
- e240
-
Epidemiology and clinicopathology in genital dermatoses: a retrospective study of 3052 skin biopsy casesJiang, Z. / Chen, H. / Chen, L. / Huang, Q. / Zhang, Q. / Zhou, J. / Li, Q. / Wang, D. / Jiang, M. / Liu, Y. et al. | 2022
- e242
-
Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanomaKohlmann, J. / Reschke, R. / Mockenhaupt, M. / Ziemer, M. et al. | 2022
- e244
-
‘Retraction artefacts’ in basal cell carcinomas do not result from fixation but likely arise by degradation of extracellular matrix during tumour growthMentzel, J. / Anderegg, U. / Paasch, U. / Simon, J.C. / Grupp, M. / Grunewald, S. et al. | 2022